双特异性受体诱蛋白通过同时阻断血管内皮生长因子A和C来阻断眼球新血管化
Paul R Sargunas1, Emily Ariail2, Raquel Lima E Silva3
1Department of Chemical and Biomedical Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, MD 21218, USA; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
概括
新的双特异诱蛋白通过向多个血管内皮生长因子 (VEGF) 配体,有效地抑制眼球新血管化,为抗现有治疗方法的眼病提供了有前途的治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 眼部新血管化导致几种眼部疾病的视力丧失.
- 血管内皮生长因子 (VEGF) 配体通过激活VEGF受体 (VEGFRs) 来诱导新血管化.
- 目前的抗VEGF疗法在一些患者中是无效的,原因是耐药性或替代VEGF连接体上调节.
研究的目的:
- 设计新的双特异性受体诱融合蛋白,用于全面抑制VEGF通路.
- 评估这些工程蛋白质在阻断VEGF活性和抑制眼睛新血管化的有效性.
主要方法:
- 工程双特异融合蛋白包含VEGFR-1和VEGFR-2域.
- 评估了与所有VEGF配体的蛋白质结合和同时配体绑定.
- 在体外评估了内皮细胞增殖,迁移和生存的抑制.
- 在小鼠模型中测试了减少眼球新血管化的有效性.
主要成果:
- 工程蛋白质结合所有VEGF连接体,并可以同时隔离两个.
- 证明了人类内皮细胞功能的强烈抑制.
- 在小鼠模型中显著减少了眼部新血管化,超过了标准的抗VEGF疗法.
结论:
- 工程诱蛋白为广泛的VEGF通路抑制提供了一种新的方法.
- 这些分子对眼部疾病具有治疗潜力,治疗选择有限.
- 代表了对抗性或不响应性眼球新血管化病例的有希望的新治疗范式.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
01:27Open Angle Glaucoma: Treatment
375
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
375
01:27Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450